共 191 条
[1]
Zhang XH(2021)The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update J Hematol Oncol 14 145-1664
[2]
Chen J(2018)The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology J Hematol Oncol 11 33-2947
[3]
Han MZ(2021)Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years Bone Marrow Transplant 56 1651-177
[4]
Huang H(2021)Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group Bone Marrow Transplant 56 2940-1163
[5]
Jiang EL(2018)What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? J Intern Med 283 166-e167
[6]
Jiang M(2012)First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation Biol Blood Marrow Transplant 18 1150-680
[7]
Xu L(2020)Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European society for blood and marrow transplantation Lancet Haematol 7 e157-988
[8]
Chen H(2019)The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia Blood Adv 3 670-1382
[9]
Chen J(2019)Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation Curr Med Res Opin 35 983-850
[10]
Han M(2020)Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation Transplant Infect Dis 22 e13217-200